ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
GXAI
Gaxos.ai Inc.
There isn't enough reported data to score GXAI yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
GXAI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
GXAI's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
GXAI PE Valuation
GXAI has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
GXAI Forward outlook
There aren't enough analyst estimates for GXAI to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
GXAI has the stronger earnings trend. Trailing diluted EPS is down 273% for ASTS versus GXAI down 115%.
GXAI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$3.00 | +$0.61 |
| Q2 2024 | -$3.23 | -$0.08 |
| Q1 2024 | -$3.23 | -$0.34 |
| Q4 2023 | -$4.00 | -$2.48 |
GXAI is still losing money, but far less than before: $0.44 per share over the past year, against $4.00 at its worst in late 2023.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
GXAI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.8M | +465% |
| Q2 2026 | $2.5M | +1337% |
| Q1 2026 | $1.8M | +7524% |
| Q4 2025 | $1.2M | +94996% |
| Q3 2025 | $498.3K | +18327% |
| Q1 2025 | $23.7K | +124805% |
GXAI's revenue has grown year over year for nine quarters in a row: $3M last quarter, up 465% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -40% | +224 points |
| Q2 2026 | -76% | +499 points |
| Q1 2026 | -141% | +5723 points |
| Q4 2025 | -99% | +68873 points |
| Q3 2025 | -264% | +33237 points |
| Q2 2025 | -575% | N/A |
| Q1 2025 | -5864% | +5488025 points |
| Q4 2024 | -68972% | N/A |
GXAI has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
GXAI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$956.7K | +$149.6K |
| Q2 2026 | -$1.1M | -$370.9K |
| Q1 2026 | -$2.5M | -$1.2M |
| Q4 2025 | -$733.1K | +$35.1K |
| Q3 2025 | -$1.1M | -$432K |
| Q2 2025 | -$716.9K | +$21.6K |
| Q1 2025 | -$1.3M | -$198.1K |
| Q4 2024 | -$768.2K | -$95.3K |
GXAI has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over GXAI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
GXAI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +17% | +1.8M shares |
| 1 year | +71% | +5.1M shares |
| 3 years | +1198% | +11.2M shares |
GXAI has 12M diluted shares, up 71% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $19,602 |
| Q4 2023 | $50,026 |
| Q3 2023 | $25,469 |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GXAI Net Leverage
GXAI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
GXAI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.1 | Neutral |
| Stochastic | 5.1 | Oversold |
GXAI's weekly RSI is 30 (neutral) and its Stochastic is 5 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
GXAI PE vs Technology Sector
GXAI has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has stronger trend alignment. ASTS is above 1 of 5 weekly averages versus GXAI above 0 of 4.
GXAI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.46 | 6.5% below |
| 20 week MA | $0.71 | 39% below |
| 50 week MA | $1.03 | 58% below |
| 100 week MA | $1.27 | 66% below |
GXAI is in a downtrend: it's below all four of its weekly moving averages, and 66% below its 100-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over GXAI on returns for 2026, with the stronger performance.
GXAI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $45.7 | $4.08 | -91% |
| 2024 | $4.08 | $2.97 | -27% |
| 2025 | $2.97 | $1.06 | -64% |
| 2026 YTD | $1.06 | $0.43 | -59% |
GXAI has finished every year since 2023 lower, and it's down 59% so far in 2026.